Astratus
Reading, GB · 1 known investors
Astratus develops a semi-automated laboratory platform using a microcapillary "dip and test" cassette and instrument reader for rapid antimicrobial susceptibility testing (AST), delivering results in under 6 hours directly from urine or bacterial isolates. It serves human, veterinary, and research markets, supporting clinical laboratories with antimicrobial stewardship and researchers developing new antimicrobials and therapies.
Founders & leadership
DO
Dr Oliver HancoxChief Executive Officer